Umeken Supplements

Our assessment

Based on FDA adverse event data, the overall safety profile for this supplement is concerning. The data shows a significant number of serious adverse events, including hospitalizations and life-threatening outcomes. This is not a supplement to take lightly; the risks must be carefully weighed against any potential benefits. Based on FDA data, this product is associated with serious safety signals that warrant caution FDA FAERS ↗.

Safety profile

FDA received 1 adverse event report for this product. The single report documented a serious outcome classified as "Other Serious (Important Medical Event)". The specific side effects reported included: atrial fibrillation, cardiac arrest, cardiomyopathy, cardiopulmonary failure, cholelithiasis, chronic kidney disease, coronary artery disease, decreased appetite, dysphagia, dyspnoea, fatigue, gastrooesophageal reflux disease, hyperkalemia, hypertension, hyponatremia, nausea, oedema peripheral, pleural effusion, pneumonia, pulmonary oedema, renal failure, respiratory failure, and ventricular tachycardia. All of these side effects are from a single report FDA FAERS ↗.

How it works

Data not available. No mechanism of action or clinical study data was provided in the data set for this supplement [Data not available].

Our recommendation

Given the single FDA adverse event report documenting multiple, severe, and life-threatening side effects, this supplement should not be used without direct medical supervision. Patients with pre-existing heart conditions, kidney disease, or electrolyte imbalances are at particularly high risk. Do not take this product without first consulting a physician. This is not a standard multivitamin; the reported risks are extreme FDA FAERS ↗.